Search

Author/Creator Strubbe, Beatrijs

1. Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab. (3rd October 2018)

Authors:
Moens, Annick; van Hoeve, Karen; Humblet, Evelien; Rahier, Jean-François; Bossuyt, Peter; Dewit, Sophie; Franchimont, Denis; Macken, Elisabeth; Nijs, Jochen; Posen, Annelies; Strubbe, Beatrijs; Van Hootegem, Anneleen; Van Moerkercke, Wouter; Vermeire, Séverine; Ferrante, Marc
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13:Number 1(2019)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Role of integrin expression in the prediction of response to vedolizumab: A prospective real‐life multicentre cohort study. Issue 4 (5th April 2022)

Authors:
De Galan, Cara; Gonzales, Gerard Bryan; Van Welden, Sophie; Tavernier, Simon Jan; Lobaton, Triana; Van Moerkercke, Wouter; Strubbe, Beatrijs; Peeters, Harald; Macken, Elisabeth; De Vos, Martine; Laukens, Debby; Hindryckx, Pieter
Journal:
Clinical and translational medicine
Issue:
Volume 12:Issue 4(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic Trial. (23rd July 2021)

Authors:
Bossuyt, Peter; Pouillon, Lieven; Claeys, Sophie; D'Haens, Soetkin; Hoefkens, Eveline; Strubbe, Beatrijs; Marichal, Denis; Peeters, Harald
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16:Number 2(2022)
Page Start:
199
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗